Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Inventory (2023 - 2025)

Historic Inventory for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $5.7 million.

  • Tonix Pharmaceuticals Holding's Inventory fell 2776.45% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 2776.45%. This contributed to the annual value of $8.4 million for FY2024, which is 3835.33% down from last year.
  • According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Inventory is $5.7 million, which was down 2776.45% from $6.0 million recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's Inventory's 5-year high stood at $13.7 million during Q2 2023, with a 5-year trough of $5.7 million in Q3 2025.
  • For the 3-year period, Tonix Pharmaceuticals Holding's Inventory averaged around $9.9 million, with its median value being $8.9 million (2024).
  • Per our database at Business Quant, Tonix Pharmaceuticals Holding's Inventory tumbled by 4053.83% in 2024 and then plummeted by 2776.45% in 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Inventory (Quarter) stood at $13.6 million in 2023, then crashed by 38.35% to $8.4 million in 2024, then tumbled by 31.86% to $5.7 million in 2025.
  • Its Inventory stands at $5.7 million for Q3 2025, versus $6.0 million for Q2 2025 and $8.1 million for Q1 2025.